Literature DB >> 24141571

Fine mapping on chromosome 13q32-34 and brain expression analysis implicates MYO16 in schizophrenia.

Laura Rodriguez-Murillo1, Bin Xu2, J Louw Roos3, Gonçalo R Abecasis4, Joseph A Gogos5, Maria Karayiorgou1.   

Abstract

We previously reported linkage of schizophrenia and schizoaffective disorder to 13q32-34 in the European descent Afrikaner population from South Africa. The nature of genetic variation underlying linkage peaks in psychiatric disorders remains largely unknown and both rare and common variants may be contributing. Here, we examine the contribution of common variants located under the 13q32-34 linkage region. We used densely spaced SNPs to fine map the linkage peak region using both a discovery sample of 415 families and a meta-analysis incorporating two additional replication family samples. In a second phase of the study, we use one family-based data set with 237 families and independent case-control data sets for fine mapping of the common variant association signal using HapMap SNPs. We report a significant association with a genetic variant (rs9583277) within the gene encoding for the myosin heavy-chain Myr 8 (MYO16), which has been implicated in neuronal phosphoinositide 3-kinase signaling. Follow-up analysis of HapMap variation within MYO16 in a second set of Afrikaner families and additional case-control data sets of European descent highlighted a region across introns 2-6 as the most likely region to harbor common MYO16 risk variants. Expression analysis revealed a significant increase in the level of MYO16 expression in the brains of schizophrenia patients. Our results suggest that common variation within MYO16 may contribute to the genetic liability to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24141571      PMCID: PMC3924527          DOI: 10.1038/npp.2013.293

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  Identification of loci associated with schizophrenia by genome-wide association and follow-up.

Authors:  Michael C O'Donovan; Nicholas Craddock; Nadine Norton; Hywel Williams; Timothy Peirce; Valentina Moskvina; Ivan Nikolov; Marian Hamshere; Liam Carroll; Lyudmila Georgieva; Sarah Dwyer; Peter Holmans; Jonathan L Marchini; Chris C A Spencer; Bryan Howie; Hin-Tak Leung; Annette M Hartmann; Hans-Jürgen Möller; Derek W Morris; Yongyong Shi; GuoYin Feng; Per Hoffmann; Peter Propping; Catalina Vasilescu; Wolfgang Maier; Marcella Rietschel; Stanley Zammit; Johannes Schumacher; Emma M Quinn; Thomas G Schulze; Nigel M Williams; Ina Giegling; Nakao Iwata; Masashi Ikeda; Ariel Darvasi; Sagiv Shifman; Lin He; Jubao Duan; Alan R Sanders; Douglas F Levinson; Pablo V Gejman; Sven Cichon; Markus M Nöthen; Michael Gill; Aiden Corvin; Dan Rujescu; George Kirov; Michael J Owen; Nancy G Buccola; Bryan J Mowry; Robert Freedman; Farooq Amin; Donald W Black; Jeremy M Silverman; William F Byerley; C Robert Cloninger
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

2.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

3.  Common genetic variants on 5p14.1 associate with autism spectrum disorders.

Authors:  Kai Wang; Haitao Zhang; Deqiong Ma; Maja Bucan; Joseph T Glessner; Brett S Abrahams; Daria Salyakina; Marcin Imielinski; Jonathan P Bradfield; Patrick M A Sleiman; Cecilia E Kim; Cuiping Hou; Edward Frackelton; Rosetta Chiavacci; Nagahide Takahashi; Takeshi Sakurai; Eric Rappaport; Clara M Lajonchere; Jeffrey Munson; Annette Estes; Olena Korvatska; Joseph Piven; Lisa I Sonnenblick; Ana I Alvarez Retuerto; Edward I Herman; Hongmei Dong; Ted Hutman; Marian Sigman; Sally Ozonoff; Ami Klin; Thomas Owley; John A Sweeney; Camille W Brune; Rita M Cantor; Raphael Bernier; John R Gilbert; Michael L Cuccaro; William M McMahon; Judith Miller; Matthew W State; Thomas H Wassink; Hilary Coon; Susan E Levy; Robert T Schultz; John I Nurnberger; Jonathan L Haines; James S Sutcliffe; Edwin H Cook; Nancy J Minshew; Joseph D Buxbaum; Geraldine Dawson; Struan F A Grant; Daniel H Geschwind; Margaret A Pericak-Vance; Gerard D Schellenberg; Hakon Hakonarson
Journal:  Nature       Date:  2009-04-28       Impact factor: 49.962

4.  Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Authors:  Tom Walsh; Jon M McClellan; Shane E McCarthy; Anjené M Addington; Sarah B Pierce; Greg M Cooper; Alex S Nord; Mary Kusenda; Dheeraj Malhotra; Abhishek Bhandari; Sunday M Stray; Caitlin F Rippey; Patricia Roccanova; Vlad Makarov; B Lakshmi; Robert L Findling; Linmarie Sikich; Thomas Stromberg; Barry Merriman; Nitin Gogtay; Philip Butler; Kristen Eckstrand; Laila Noory; Peter Gochman; Robert Long; Zugen Chen; Sean Davis; Carl Baker; Evan E Eichler; Paul S Meltzer; Stanley F Nelson; Andrew B Singleton; Ming K Lee; Judith L Rapoport; Mary-Claire King; Jonathan Sebat
Journal:  Science       Date:  2008-03-27       Impact factor: 47.728

Review 5.  Meta-analysis in genome-wide association studies.

Authors:  Eleftheria Zeggini; John P A Ioannidis
Journal:  Pharmacogenomics       Date:  2009-02       Impact factor: 2.533

6.  Strong association of de novo copy number mutations with sporadic schizophrenia.

Authors:  Bin Xu; J Louw Roos; Shawn Levy; E J van Rensburg; Joseph A Gogos; Maria Karayiorgou
Journal:  Nat Genet       Date:  2008-05-30       Impact factor: 38.330

7.  Common variants conferring risk of schizophrenia.

Authors:  Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

Review 8.  Neuroligins and neurexins link synaptic function to cognitive disease.

Authors:  Thomas C Südhof
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

9.  A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis.

Authors:  Eugénia Cruz; Chris Whittington; Samuel H Krikler; Cláudia Mascarenhas; Rosa Lacerda; Jorge Vieira; Graça Porto
Journal:  BMC Med Genet       Date:  2008-11-06       Impact factor: 2.103

10.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

View more
  10 in total

1.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

Review 2.  Recent progress in the genetics of diabetic microvascular complications.

Authors:  Yi-Cheng Chang; Emily Yun-Chia Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2015-06-10

3.  Identification of Amino Acid Residues in Fibroblast Growth Factor 14 (FGF14) Required for Structure-Function Interactions with Voltage-gated Sodium Channel Nav1.6.

Authors:  Syed R Ali; Aditya K Singh; Fernanda Laezza
Journal:  J Biol Chem       Date:  2016-03-18       Impact factor: 5.157

4.  Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.

Authors:  Wei-Chun Hsu; Miroslav N Nenov; Alexander Shavkunov; Neli Panova; Ming Zhan; Fernanda Laezza
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

5.  Gene-body 5-hydroxymethylation is associated with gene expression changes in the prefrontal cortex of depressed individuals.

Authors:  J A Gross; A Pacis; G G Chen; M Drupals; P-E Lutz; L B Barreiro; G Turecki
Journal:  Transl Psychiatry       Date:  2017-05-09       Impact factor: 6.222

6.  Altered gene expression in antipsychotic-induced weight gain.

Authors:  Benedicto Crespo-Facorro; Carlos Prieto; Jesus Sainz
Journal:  NPJ Schizophr       Date:  2019-04-10

Review 7.  Myosin XVI in the Nervous System.

Authors:  Elek Telek; András Kengyel; Beáta Bugyi
Journal:  Cells       Date:  2020-08-15       Impact factor: 6.600

8.  Multi-trait GWAS using imputed high-density genotypes from whole-genome sequencing identifies genes associated with body traits in Nile tilapia.

Authors:  Grazyella M Yoshida; José M Yáñez
Journal:  BMC Genomics       Date:  2021-01-15       Impact factor: 3.969

9.  Positive Selection and Enhancer Evolution Shaped Lifespan and Body Mass in Great Apes.

Authors:  Daniela Tejada-Martinez; Roberto A Avelar; Inês Lopes; Bruce Zhang; Guy Novoa; João Pedro de Magalhães; Marco Trizzino
Journal:  Mol Biol Evol       Date:  2022-02-03       Impact factor: 16.240

10.  Identification of Susceptible Loci and Enriched Pathways for Bipolar II Disorder Using Genome-Wide Association Studies.

Authors:  Chung-Feng Kao; Hui-Wen Chen; Hsi-Chung Chen; Jenn-Hwai Yang; Ming-Chyi Huang; Yi-Hang Chiu; Shih-Ku Lin; Ya-Chin Lee; Chih-Min Liu; Li-Chung Chuang; Chien-Hsiun Chen; Jer-Yuarn Wu; Ru-Band Lu; Po-Hsiu Kuo
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-03       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.